Charles Schwab: Sabra Healthcare REIT SBRA Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 102 M | Compra |
5,155,856
+315,455
| +7% | +USD 6.47 M | 0.01% | 783 |
|
|
2026
Q2 | USD 94.4 M | Compra |
4,840,401
+67,098
| +1% | +USD 1.33 M | 0.01% | 822 |
|
|
2026
Q1 | USD 91.8 M | Compra |
4,773,303
+49,757
| +1% | +USD 980 k | 0.01% | 775 |
|
|
2025
Q4 | USD 89.5 M | Compra |
4,723,546
+334,737
| +8% | +USD 6.2 M | 0.01% | 787 |
|
|
2025
Q3 | USD 81.8 M | Venta |
4,388,809
-58,558
| -1% | -USD 1.09 M | 0.01% | 828 |
|
|
2025
Q2 | USD 82 M | Venta |
4,447,367
-263,913
| -6% | -USD 4.68 M | 0.01% | 773 |
|
|
2025
Q1 | USD 82.3 M | Compra |
4,711,280
+6,317
| +0.1% | +USD 107 k | 0.02% | 753 |
|
|
2024
Q4 | USD 81.5 M | Compra |
4,704,963
+3,082
| +0.1% | +USD 56.3 k | 0.02% | 782 |
|
|
2024
Q3 | USD 87.5 M | Compra |
4,701,881
+365,855
| +8% | +USD 6.17 M | 0.02% | 745 |
|
|
2024
Q2 | USD 66.8 M | Compra |
4,336,026
+87,514
| +2% | +USD 1.25 M | 0.01% | 853 |
|
|
2024
Q1 | USD 62.8 M | Compra |
4,248,512
+57,925
| +1% | +USD 802 k | 0.01% | 860 |
|
|
2023
Q4 | USD 59.8 M | Compra |
4,190,587
+94,304
| +2% | +USD 1.34 M | 0.02% | 852 |
|
|
2023
Q3 | USD 57.1 M | Compra |
4,096,283
+116,444
| +3% | +USD 1.49 M | 0.02% | 795 |
|
|
2023
Q2 | USD 46.8 M | Compra |
3,979,839
+18,926
| +0.5% | +USD 215 k | 0.01% | 892 |
|
|
2023
Q1 | USD 45.6 M | Compra |
3,960,913
+56,583
| +1% | +USD 700 k | 0.01% | 907 |
|
|
2022
Q4 | USD 48.5 M | Compra |
3,904,330
+89,808
| +2% | +USD 1.15 M | 0.02% | 837 |
|
|
2022
Q3 | USD 50 M | Compra |
3,814,522
+29,954
| +0.8% | +USD 443 k | 0.02% | 755 |
|
|
2022
Q2 | USD 52.9 M | Compra |
3,784,568
+163,373
| +5% | +USD 2.18 M | 0.02% | 717 |
|
|
2022
Q1 | USD 53.9 M | Compra |
3,621,195
+193,550
| +6% | +USD 2.65 M | 0.02% | 825 |
|
|
2021
Q4 | USD 46.4 M | Compra |
3,427,645
+285,064
| +9% | +USD 4.03 M | 0.01% | 948 |
|
|
2021
Q3 | USD 46.3 M | Compra |
3,142,581
+205,496
| +7% | +USD 3.47 M | 0.02% | 931 |
|
|
2021
Q2 | USD 53.5 M | Compra |
2,937,085
+63,741
| +2% | +USD 1.13 M | 0.02% | 814 |
|
|
2021
Q1 | USD 49.9 M | Compra |
2,873,344
+8,895
| +0.3% | +USD 156 k | 0.02% | 829 |
|
|
2020
Q4 | USD 49.8 M | Compra |
2,864,449
+46,470
| +2% | +USD 742 k | 0.02% | 769 |
|
|
2020
Q3 | USD 38.8 M | Venta |
2,817,979
-24,002
| -0.8% | -USD 353 k | 0.02% | 793 |
|
|
2020
Q2 | USD 41 M | Compra |
2,841,981
+527,377
| +23% | +USD 6.93 M | 0.02% | 706 |
|
|
2020
Q1 | USD 25.3 M | Compra |
2,314,604
+428,199
| +23% | +USD 7.9 M | 0.01% | 851 |
|
|
2019
Q4 | USD 40.3 M | Compra |
1,886,405
+478,800
| +34% | +USD 10.7 M | 0.02% | 751 |
|
|
2019
Q3 | USD 32.3 M | Compra |
1,407,605
+112,387
| +9% | +USD 2.4 M | 0.02% | 854 |
|
|
2019
Q2 | USD 25.5 M | Compra |
1,295,218
+15,022
| +1% | +USD 293 k | 0.02% | 977 |
|
|
2019
Q1 | USD 24.9 M | Compra |
1,280,196
+19,809
| +2% | +USD 375 k | 0.02% | 969 |
|
|
2018
Q4 | USD 20.8 M | Compra |
1,260,387
+24,308
| +2% | +USD 489 k | 0.02% | 976 |
|
|
2018
Q3 | USD 28.6 M | Compra |
1,236,079
+21,567
| +2% | +USD 489 k | 0.02% | 899 |
|
|
2018
Q2 | USD 26.4 M | Compra |
1,214,512
+64,647
| +6% | +USD 1.26 M | 0.02% | 886 |
|
|
2018
Q1 | USD 20.3 M | Compra |
1,149,865
+72,029
| +7% | +USD 1.27 M | 0.02% | 992 |
|
|
2017
Q4 | USD 20.2 M | Venta |
1,077,836
-62,298
| -5% | -USD 1.24 M | 0.02% | 969 |
|
|
2017
Q3 | USD 25 M | Compra |
1,140,134
+580,906
| +104% | +USD 13.1 M | 0.02% | 757 |
|
|
2017
Q2 | USD 13.5 M | Compra |
559,228
+57,014
| +11% | +USD 1.45 M | 0.01% | 1127 |
|
|
2017
Q1 | USD 14 M | Venta |
502,214
-57,813
| -10% | -USD 1.52 M | 0.01% | 1068 |
|
|
2016
Q4 | USD 13.7 M | Compra |
560,027
+25,343
| +5% | +USD 581 k | 0.02% | 1026 |
|
|
2016
Q3 | USD 13.5 M | Compra |
534,684
+199,870
| +60% | +USD 4.79 M | 0.02% | 947 |
|
|
2016
Q2 | USD 6.91 M | Compra |
334,814
+26,038
| +8% | +USD 543 k | 0.01% | 1330 |
|
|
2016
Q1 | USD 6.2 M | Compra |
308,776
+10,886
| +4% | +USD 209 k | 0.01% | 1377 |
|
|
2015
Q4 | USD 6.03 M | Compra |
297,890
+31,004
| +12% | +USD 653 k | 0.01% | 1386 |
|
|
2015
Q3 | USD 6.19 M | Compra |
266,886
+23,024
| +9% | +USD 587 k | 0.01% | 1331 |
|
|
2015
Q2 | USD 6.28 M | Compra |
243,862
+16,100
| +7% | +USD 457 k | 0.01% | 1399 |
|
|
2015
Q1 | USD 7.55 M | Venta |
227,762
-4,324
| -2% | -USD 140 k | 0.01% | 1204 |
|
|
2014
Q4 | USD 7.05 M | Compra |
232,086
+61,803
| +36% | +USD 1.7 M | 0.01% | 1164 |
|
|
2014
Q3 | USD 4.14 M | Compra |
170,283
+12,582
| +8% | +USD 349 k | 0.01% | 1532 |
|
|
2014
Q2 | USD 4.53 M | Compra |
157,701
+21,921
| +16% | +USD 637 k | 0.01% | 1483 |
|
|
2014
Q1 | USD 3.79 M | Compra |
135,780
+16,200
| +14% | +USD 445 k | 0.01% | 1549 |
|
|
2013
Q4 | USD 3.13 M | Compra |
119,580
+15,887
| +15% | +USD 410 k | 0.01% | 1624 |
|
|
2013
Q3 | USD 2.46 M | Compra |
103,693
+10,071
| +11% | +USD 248 k | 0.01% | 1722 |
|
|
2013
Q2 | USD 2.47 M | Compra |
+93,622
| Nuevas | +USD 2.7 M | 0.01% | 1625 |
|
Otros fondos que tienen SBRA en su portafolio
Posición de Charles Schwab en SBRA: resumen de T3 2026
Charles Schwab aumentó su participación en Sabra Healthcare REIT (SBRA) en 6.5% durante T3 2026, al comprar aproximadamente USD 6.47 M y elevar la posición a 5,155,856 acciones con un valor de USD 102 M. La posición representa 0.01% del portafolio y ocupa el puesto #783.
Charles Schwab reportó por primera vez una posición en SBRA en T2 2013 y desde entonces la ha mantenido en 54 trimestres. Al cierre de T3 2026, 458 fondos que sigue Wall St. Rank mantienen una posición en SBRA.
- Al cierre de T3 2026, Charles Schwab tenía 5,155,856 acciones de Sabra Healthcare REIT con un valor de USD 102 M.
- Charles Schwab compró 315,455 acciones de Sabra Healthcare REIT en T3 2026, por un monto estimado de USD 6.47 M.
- Sabra Healthcare REIT representó el 0.01% del portafolio de Charles Schwab en T3 2026 y fue su posición número 783.
- Charles Schwab reportó por primera vez una posición en Sabra Healthcare REIT en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- Al cierre de T3 2026, 458 fondos que sigue Wall St. Rank tenían Sabra Healthcare REIT en su portafolio.
Según el informe 13F de Charles Schwab correspondiente a T3 2026, presentado el 16 nov 2026.